Panacea Biotec

Panacea Biotec crashes 9.99% leading BSE 'B' group losers

1 Source

3 months ago

Panacea Biotec shares surge 60% in 6 days on dengue vaccine project

3 Sources

3 months ago

Panacea Biotec surges 56% in 6 sessions on DENSTAR dengue vaccine trial

3 Sources

3 months ago

Panacea Biotec's DENSTAR project launches June 1, 2026 for African dengue vaccine licensure

3 Sources

3 months ago

Panacea Biotec posts ₹0.52 cr Q4 profit vs ₹1.89 cr loss last year

2 Sources

3 months ago

Panacea Biotec shares surge 6% on dengue vaccine milestone

5 Sources

8 months ago